195 related articles for article (PubMed ID: 30459443)
1. CMV and EBV targets recognized by tumor-infiltrating B lymphocytes in pancreatic cancer and brain tumors.
Meng Q; Valentini D; Rao M; Dodoo E; Maeurer M
Sci Rep; 2018 Nov; 8(1):17079. PubMed ID: 30459443
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus- and cytomegalovirus-specific immune response in patients with brain cancer.
Liu Z; Poiret T; Meng Q; Rao M; von Landenberg A; Schoutrop E; Valentini D; Dodoo E; Peredo-Harvey I; Maeurer M
J Transl Med; 2018 Jul; 16(1):182. PubMed ID: 29970101
[TBL] [Abstract][Full Text] [Related]
3. Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma.
Zhu QY; Kong XW; Sun C; Xie SH; Hildesheim A; Cao SM; Zeng MS
mSphere; 2020 Dec; 5(6):. PubMed ID: 33268566
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous ex vivo expansion of cytomegalovirus and Epstein-Barr virus-specific cytotoxic T lymphocytes using B-lymphoblastoid cell lines expressing cytomegalovirus pp65.
Sun Q; Pollok KE; Burton RL; Dai LJ; Britt W; Emanuel DJ; Lucas KG
Blood; 1999 Nov; 94(9):3242-50. PubMed ID: 10556213
[TBL] [Abstract][Full Text] [Related]
6. An overview of the infection of CMV, HSV 1/2 and EBV in Mexican patients with glioblastoma multiforme.
Zavala-Vega S; Castro-Escarpulli G; Hernández-Santos H; Salinas-Lara C; Palma I; Mejía-Aranguré JM; Gelista-Herrera N; Rembao-Bojorquez D; Ochoa SA; Cruz-Córdova A; Xicohtencatl-Cortes J; Uribe-Gutiérrez G; Arellano-Galindo J
Pathol Res Pract; 2017 Mar; 213(3):271-276. PubMed ID: 28215646
[TBL] [Abstract][Full Text] [Related]
7. Latent Epstein-Barr virus (EBV) infection and cytomegalovirus (CMV) infection in synovial tissue of autoimmune chronic arthritis determined by RNA- and DNA-in situ hybridization.
Mehraein Y; Lennerz C; Ehlhardt S; Remberger K; Ojak A; Zang KD
Mod Pathol; 2004 Jul; 17(7):781-9. PubMed ID: 15044921
[TBL] [Abstract][Full Text] [Related]
8. EBV-specific immune responses in patients with multiple sclerosis responding to IFNβ therapy.
Comabella M; Kakalacheva K; Río J; Münz C; Montalban X; Lünemann JD
Mult Scler; 2012 May; 18(5):605-9. PubMed ID: 22020417
[TBL] [Abstract][Full Text] [Related]
9. Carcinoembryonic antigen-specific but not antiviral CD4+ T cell immunity is impaired in pancreatic carcinoma patients.
Tassi E; Gavazzi F; Albarello L; Senyukov V; Longhi R; Dellabona P; Doglioni C; Braga M; Di Carlo V; Protti MP
J Immunol; 2008 Nov; 181(9):6595-603. PubMed ID: 18941250
[TBL] [Abstract][Full Text] [Related]
10. Is cytomegalovirus a therapeutic target in glioblastoma?
Sampson JH; Mitchell DA
Clin Cancer Res; 2011 Jul; 17(14):4619-21. PubMed ID: 21632859
[TBL] [Abstract][Full Text] [Related]
11. Tumor-infiltrating B lymphocytes as a potential source of identifying tumor antigen in human lung cancer.
Yasuda M; Takenoyama M; Obata Y; Sugaya M; So T; Hanagiri T; Sugio K; Yasumoto K
Cancer Res; 2002 Mar; 62(6):1751-6. PubMed ID: 11912150
[TBL] [Abstract][Full Text] [Related]
12. Altered humoral immunity against cytomegalovirus and Epstein-Barr virus without detectable virus antigens and virus-DNA in the glomeruli of patients with IGA nephropathy in remission phase.
Nagy J; Haikin H; Sarov B; Háber A; Kun L; Sarov I
Acta Microbiol Immunol Hung; 1995; 42(2):179-87. PubMed ID: 7551711
[TBL] [Abstract][Full Text] [Related]
13. Antigen Specificity and Clinical Significance of IgG and IgA Autoantibodies Produced
Garaud S; Zayakin P; Buisseret L; Rulle U; Silina K; de Wind A; Van den Eyden G; Larsimont D; Willard-Gallo K; Linē A
Front Immunol; 2018; 9():2660. PubMed ID: 30515157
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer, cytomegalovirus and Epstein-Barr virus: a nested case-control study.
Cox B; Richardson A; Graham P; Gislefoss RE; Jellum E; Rollag H
Br J Cancer; 2010 May; 102(11):1665-9. PubMed ID: 20407437
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus-seropositive children show inhibition of in vitro EBV infection that is associated with CD8+CD57+ T cell enrichment and IFN-γ.
Sohlberg E; Saghafian-Hedengren S; Rasul E; Marchini G; Nilsson C; Klein E; Nagy N; Sverremark-Ekström E
J Immunol; 2013 Dec; 191(11):5669-76. PubMed ID: 24140645
[TBL] [Abstract][Full Text] [Related]
16. Effects of aging, cytomegalovirus infection, and EBV infection on human B cell repertoires.
Wang C; Liu Y; Xu LT; Jackson KJ; Roskin KM; Pham TD; Laserson J; Marshall EL; Seo K; Lee JY; Furman D; Koller D; Dekker CL; Davis MM; Fire AZ; Boyd SD
J Immunol; 2014 Jan; 192(2):603-11. PubMed ID: 24337376
[TBL] [Abstract][Full Text] [Related]
17. Increased frequency of EBV-specific effector memory CD8+ T cells correlates with higher viral load in rheumatoid arthritis.
Lünemann JD; Frey O; Eidner T; Baier M; Roberts S; Sashihara J; Volkmer R; Cohen JI; Hein G; Kamradt T; Münz C
J Immunol; 2008 Jul; 181(2):991-1000. PubMed ID: 18606650
[TBL] [Abstract][Full Text] [Related]
18. A repetitive sequence of Epstein-Barr virus nuclear antigen 6 comprises overlapping T cell epitopes which induce HLA-DR-restricted CD4(+) T lymphocytes.
Rajnavölgyi E; Nagy N; Thuresson B; Dosztányi Z; Simon A; Simon I; Karr RW; Ernberg I; Klein E; Falk KI
Int Immunol; 2000 Mar; 12(3):281-93. PubMed ID: 10700463
[TBL] [Abstract][Full Text] [Related]
19. Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma.
Ghazi A; Ashoori A; Hanley PJ; Brawley VS; Shaffer DR; Kew Y; Powell SZ; Grossman R; Grada Z; Scheurer ME; Hegde M; Leen AM; Bollard CM; Rooney CM; Heslop HE; Gottschalk S; Ahmed N
J Immunother; 2012; 35(2):159-68. PubMed ID: 22306904
[TBL] [Abstract][Full Text] [Related]
20. [A prognostic value of level of antiviral antibodies in the development of recurrence of bladder cancer].
Kosova IV; Loran OB; Sinyakova LA; Gundorova LV; Kosov VA; Pogodina IE; Kolbasov DN
Urologiia; 2018 Dec; (6):86-94. PubMed ID: 30742384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
